Prognostic analysis of patients who underwent gross total resection of newly diagnosed glioblastoma

被引:12
|
作者
Matsuda, Masahide [1 ]
Kohzuki, Hidehiro [1 ]
Ishikawa, Eiichi [1 ]
Yamamoto, Tetsuya [1 ]
Akutsu, Hiroyoshi [1 ]
Takano, Shingo [1 ]
Mizumoto, Masashi [2 ]
Tsuboi, Koji [2 ]
Matsumura, Akira [1 ]
机构
[1] Univ Tsukuba, Dept Neurosurg, Fac Med, Tsukuba, Ibaraki 3058575, Japan
[2] Univ Tsukuba, Dept Radiat Oncol, Proton Med Res Ctr, Tsukuba, Ibaraki, Japan
关键词
Glioblastoma; Gross total resection; Subventricular zone; Proton beam therapy; SUBVENTRICULAR ZONE; RADIATION-THERAPY; MULTIVARIATE-ANALYSIS; MULTIFORME; SURVIVAL; IRRADIATION; CONCOMITANT; RECURRENCE; EXTENT;
D O I
10.1016/j.jocn.2018.01.009
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Despite cumulative evidence supporting the idea that gross total resection (GTR) contributes to prolonged survival of patients with glioblastoma (GBM), the survival outcome of such patients remains unsatisfactory. To develop more effective postoperative therapeutic strategies for patients who underwent GTR, identification of prognostic factors influencing survival is urgently needed. Here we retrospectively analyzed prognostic factors for patients who underwent GTR of newly diagnosed GBM, with a particular focus on the influence of the subventricular zone (SVZ) as the tumor location. Forty-eight consecutive patients with newly diagnosed GBM who underwent GTR during the initial operation were investigated. Tumor involvement of the SVZ was significantly associated with overall survival (OS). The SVZ-positive group had a significantly shorter median OS of 12.2 months, compared to 34.9 months for the SVZ-negative group. The occurrence of leptomeningeal dissemination was significantly influenced by tumor involvement of the SVZ, but was not significantly influenced by ventricular opening during surgery. We observed a statistically significant difference in OS according to radiation modality. The median OS was 36.9 months for patients treated with high-dose proton beam therapy, compared with 26.2 months for patients treated with conventional radiotherapy. We demonstrated that tumor involvement of the SVZ was associated with poor survival of patients who underwent GTR of newly diagnosed GBM, suggesting the potential need for therapeutic strategies that specifically target tumors in the SVZ. Further prospective studies to evaluate whether radiotherapy targeting the SVZ improves survival of patients with tumor involvement of the SVZ who had undergone GTR are warranted. (C) 2018 Elsevier Ltd. All rights reserved.
引用
收藏
页码:172 / 176
页数:5
相关论文
共 50 条
  • [31] Is surgical resection useful in elderly newly diagnosed glioblastoma patients? Outcome evaluation and prognostic factors assessment
    Federico Pessina
    Pierina Navarria
    Luca Cozzi
    Roberta Rudà
    Marco Conti Nibali
    Matteo Simonelli
    Francesco Costa
    Armando Santoro
    Elena Clerici
    Giulio Carta
    Marta Scorsetti
    Lorenzo Bello
    Acta Neurochirurgica, 2018, 160 : 1779 - 1787
  • [32] Rapid Interval Recurrence of Glioblastoma Following Gross Total Resection: A Possible Indication for GammaTile⊠ Brachytherapy
    Easwaran, Teresa P.
    Sterling, David
    Ferreira, Clara
    Sloan, Lindsey
    Wilke, Christopher
    Neil, Elizabeth
    Shah, Rena
    Chen, Clark C.
    Dusenbery, Kathryn E.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (11)
  • [33] Optimal Therapies for Newly Diagnosed Elderly Patients with Glioblastoma
    Ironside, Sarah
    Das, Sunit
    Sahgal, Arjun
    Moroney, Claire
    Mainprize, Todd
    Perry, James R.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2017, 18 (11)
  • [34] A Hematological-Related Prognostic Scoring System for Patients With Newly Diagnosed Glioblastoma
    Zhao, Chao
    Li, Long-Qing
    Yang, Feng-Dong
    Wei, Ruo-Lun
    Wang, Min-Kai
    Song, Di-Xiang
    Guo, Xiao-Yue
    Du, Wei
    Wei, Xin-Ting
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [35] Impact of timing of radiotherapy in patients with newly diagnosed glioblastoma
    Randolph, David M., II
    McTyre, Emory R.
    Paulsson, Anna K.
    Holmes, Jordan A.
    Hinson, William H.
    Lesser, Glenn J.
    Strowd, Roy
    Lo, Hui-Wen
    Laxton, Adrian W.
    Tatter, Stephen B.
    Debinski, Waldemar
    Chan, Michael D.
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2016, 151 : 73 - 78
  • [36] Phase I trial of gross total resection, permanent iodine-125 brachytherapy, and hyperfractionated radiotherapy for newly diagnosed glioblastoma multiforme
    Chen, Allen M.
    Chang, Susan
    Pouliot, Jean
    Sneed, Penny K.
    Prados, Michael D.
    Lamborn, Kathleen R.
    Malec, Mary K.
    McDermott, Michael W.
    Berger, Mitchell S.
    Larson, David A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : 825 - 830
  • [37] Selection of Eligible Patients with Supratentorial Glioblastoma Multiforme for Gross Total Resection
    Jun Shinoda
    Noboru Sakai
    Satoru Murase
    Hirohito Yano
    Takashi Matsuhisa
    Takashi Funakoshi
    Journal of Neuro-Oncology, 2001, 52 : 161 - 171
  • [38] Gross Total Resection Correlates with Long-Term Survival in Pediatric Patients with Glioblastoma
    Yang, Tong
    Temkin, Nancy
    Barber, Jason
    Geyer, J. Russell
    Leary, Sarah
    Browd, Samuel
    Ojemann, Jeffrey G.
    Ellenbogen, Richard G.
    WORLD NEUROSURGERY, 2013, 79 (3-4) : 537 - 544
  • [39] Delaying standard combined chemoradiotherapy after surgical resection does not impact survival in newly diagnosed glioblastoma patients
    Louvel, Guillaume
    Metellus, Philippe
    Noel, Georges
    Peeters, Sophie
    Guyotat, Jacques
    Duntze, Julien
    Le Reste, Pierre-Jean
    Phong Dam Hieu
    Faillot, Thierry
    Litre, Fabien
    Desse, Nicolas
    Petit, Antoine
    Emery, Evelyne
    Voirin, Jimmy
    Peltier, Johann
    Caire, Francois
    Vignes, Jean-Rodolphe
    Barat, Jean-Luc
    Langlois, Olivier
    Menei, Philippe
    Dumont, Sarah N.
    Zanello, Marc
    Dezamis, Edouard
    Dhermain, Frederic
    Pallud, Johan
    RADIOTHERAPY AND ONCOLOGY, 2016, 118 (01) : 9 - 15
  • [40] Selection of eligible patients with supratentorial glioblastoma multiforme for gross total resection
    Shinoda, J
    Sakai, N
    Murase, S
    Yano, H
    Matsuhisa, T
    Funakoshi, T
    JOURNAL OF NEURO-ONCOLOGY, 2001, 52 (02) : 161 - 171